Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
Abstract Background It is well known that human clear cell renal cell carcinoma (ccRCC) is a highly immunogenic and chemo-resistant tumor. Recently, emerging data suggest that the immune checkpoint blockade therapy is an important breakthrough in the treatment against ccRCC. HHLA2, a recently report...
Main Authors: | Lujun Chen, Dawei Zhu, Jun Feng, You Zhou, Qi Wang, Huijing Feng, Junping Zhang, Jingting Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-019-0813-2 |
Similar Items
-
Overexpression and Role of HHLA2, a Novel Immune Checkpoint, in Colorectal Cancer
by: Agnieszka Kula, et al.
Published: (2023-03-01) -
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
by: Yang Li, et al.
Published: (2023-05-01) -
The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma
by: Chaoqi Zhang, et al.
Published: (2022-03-01) -
Regulation of HHLA2 expression in kidney cancer and myeloid cells
by: Tomonari Shigemura, et al.
Published: (2023-10-01) -
HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma
by: Fu-xue Huang, et al.
Published: (2022-08-01)